Although Canadian guidelines for the diagnosis and management of asthma have been
published over the last 15 years, 1–4 there has been little focus on issues relevant to asthma …

Background Asthma is a common respiratory disease among both adults and children and
short acting inhaled beta‐2 agonists are used widely for'reliever'bronchodilator therapy …

Objective: To present recommendations for the prevention and screening, recognition, and
treatment of the most common conditions resulting in sudden death in organized sports …

Objectives: To educate athletic trainers and others about the need for emergency planning,
to provide guidelines in the development of emergency plans, and to advocate …

Introduction Twice-daily inhaled salmeterol for 4 weeks produces marked reducton in its
acute bronchoprotective effect against methacholine. This investigation examined the onset …

Introduction Twice-daily inhaled salmeterol produces rapid reduction in its acute
bronchoprotective effect against methacholine in patients with mild asthma. This …

" Addressing a number of practical implications for the promotion of the pharmaceutical
industry, this book will be of enormous interest to students, researchers and academics …

Asthma is generally managed with bronchodilator therapy and/or anti-inflammatory drugs.
Guidelines now advocate selection of drugs and pharmaceutical formulations (long-acting …

Effective treatments for asthma exist, but morbidity and mortality have continued to climb.
Many attempts have been made to refine rather than change therapy over the past 20 years …

There is increasing evidence for the development of tolerance to the protective effects of
inhaled beta 2-agonists against bronchoconstrictor stimuli. Animal studies have suggested …